US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alterity Therapeutics Limited

0.0030

0.0000

Volume:- -

Turnover:- -

Market Cap:26.65M

PE:-1.22

High:0.0030

Open:0.0030

Low:0.0030

Close:0.0030

52wk High:0.0139

52wk Low:0.0030

Shares:8.88B

Float Shares:8.84B

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0025

EPS(LYR):-0.0035

ROE:-155.77%

ROA:-78.37%

PB:5.23

PE(LYR):-0.86

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Alterity Therapeutics Limited

Exchange:

PINK LIMITED

Establishment Date:

1997

Employees:

10

Office Location:

350 Collins Street,Suite 4,Level 14,Melbourne,Victoria,Australia

Website:

http://www.pranabio.com

Zip Code:

3000

Phone:

Fax:

- -

Introduction:

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PRNAF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRNAF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRNAF\",,,,,undefined,":{"symbol":"PRNAF","market":"US","secType":"STK","nameCN":"Alterity Therapeutics Limited","latestPrice":0.003,"timestamp":1755113520000,"preClose":0.003,"halted":0,"volume":0,"delay":15,"floatShares":8842000000,"shares":8882000000,"eps":-0.002455,"marketStatus":"Trading","change":0,"latestTime":"08-13 15:32:00 EDT Delay","open":0.003,"high":0.003,"low":0.003,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.002455,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1755115200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":0.003,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRNAF\",,,,,undefined,":{"symbol":"PRNAF","floatShares":8842000000,"roa":"-78.37%","roe":"-155.77%","lyrEps":-0.003496,"shares":8882000000,"dividePrice":0,"high":0.003,"amplitude":0,"preClose":0.003,"low":0.003,"week52Low":0.003,"pbRate":"5.23","psRate":"10.94","week52High":0.0139,"institutionHeld":0,"latestPrice":0.003,"eps":-0.002455,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.002455,"open":0.003,"prevYearClose":0.0036,"prevWeekClose":0.003,"prevMonthClose":0.003,"prevQuarterClose":0.003,"fiveDayClose":0.003,"twentyDayClose":0.003,"sixtyDayClose":0.0139},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRNAF\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRNAF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRNAF\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":2383747,"yearFounded":1997,"employeeNum":10,"address":"350 Collins Street,Suite 4,Level 14,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9349 4906"},"stockCompanyDetail":{"websiteUrl":"http://www.pranabio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0708},{"period":"3month","weight":215.5},{"period":"6month","weight":-0.3537},{"period":"1year","weight":-0.2268},{"period":"ytd","weight":0.031}],"description":"Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.","exchange":"PINK LIMITED","name":"Alterity Therapeutics Limited","nameEN":"Alterity Therapeutics Limited"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PRNAF\",market:\"US\",,,undefined,":null}}